US Patent Issued to ATRIUM THERAPEUTICS on Aug. 18 for "Polynucleotide conjugates comprising PLN -targeting anti-transferrin receptor antibodies and method of use thereof to treat PLN -associated cardiomyopathies" (California Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,669, issued on Aug. 18, was assigned to ATRIUM THERAPEUTICS INC. (San Diego).

"Polynucleotide conjugates comprising PLN -targeting anti-transferrin receptor antibodies and method of use thereof to treat PLN -associated cardiomyopathies" was invented by Cecilia Hurtado (San Diego), Georgios Karamanlidis (Thousand Oaks, Calif.), Sami Abdulwahab Abdulkadir (San Diego), Subbarao Nallagatla (San Diego) and Maryam Jordan (Escondido, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods of use for antibody-PLN targeting oligonucleotide conjugates (AOC)."

The patent w...